X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Levodopa is the most effective medicine for the movement symptoms of Parkinson's disease. In the brain it is converted into dopamine — but first it has to pass through the gut and the blood-brain barrier, where it competes with protein building blocks from food for the same transport routes. Over the years the effect often lasts for a shorter time (wearing-off); taking it on time, timing meals cleverly and keeping good records then become part of the treatment in their own right.
See more detail.gif)
Dose times, meals and on-off phases in one history — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Levodopa (L-dopa), always combined with a decarboxylase inhibitor — benserazide or carbidopa —, sometimes with entacapone as well |
| ATC code | N04BA02 (levodopa and decarboxylase inhibitor) |
| Drug class | Dopaminergic Parkinson's medicine; precursor of the messenger substance dopamine |
| Dosage forms | Immediate-release tablets and capsules, prolonged-release forms, dispersible tablets to dissolve in water, triple combination with entacapone; as a gel via a tube into the small intestine or as an infusion under the skin (pump therapies) |
| Half-life | Short, about one and a half hours — the reason for the later fluctuations in effect |
| Maximum daily dose | Depends on the product according to the SmPC; the dose is set individually according to effect and tolerability |
| Onset of effect | Immediate-release forms usually within 30 to 60 minutes; dispersible tablets somewhat faster, prolonged-release forms slower and flatter |
| Prescription status | Prescription-only medicine |
| Notable feature | Competes with protein building blocks from food for absorption; must never be stopped abruptly |
In Parkinson's disease, the nerve cells in the midbrain that produce the messenger substance dopamine gradually die off. Dopamine is essential for smooth, automatic movements. When it is lacking, the typical symptoms appear: slowness, stiffness, tremor at rest and unsteadiness when walking.
Swallowing dopamine as a tablet does not help — it cannot get through the blood-brain barrier. Its precursor levodopa can: it is carried into the brain by a transport system for so-called large neutral amino acids, and there the remaining nerve cells convert it into dopamine.¹ This detour is the reason why levodopa is still the most effective medicine for the movement symptoms today.² And it is the reason for the competition with protein: protein building blocks from food use the same transporter (section 6).
So that levodopa is not already converted into dopamine in the blood, it is always combined with a decarboxylase inhibitor — benserazide or carbidopa. These partners do not themselves get into the brain, but they prevent premature conversion in the rest of the body. This means a lower dose of levodopa is enough, and nausea and circulatory problems are less pronounced.¹
The side effects also follow from the mechanism: dopamine in the vomiting centre of the brainstem causes nausea, dopamine acting on the blood vessels lowers blood pressure, too much dopamine in the motor system produces excess movements (dyskinesias), and dopamine in other regions of the brain can alter perception, sleep and drive.
The figures below describe the approach given in the SmPCs.¹ They are not a dosing recommendation — the dose, the product and how it is spread over the day are set by the treating neurology practice.
For a long time there was a widespread fear that levodopa should be started as late as possible because it "gets used up" or speeds up the course of the disease. A large study has shown that starting early neither speeds up nor slows down the course of the disease.³ Fluctuations in effect and excess movements depend more on how long the disease has lasted and on the dose than on when treatment started. The current guideline therefore sees no reason to delay levodopa for fear of late effects; which substance is used first depends on age, symptoms and the risk of side effects.²
With hardly any other medicine does the time of day decide so much about the effect. In advanced stages, being half an hour late can mean that you can no longer get out of your armchair.
A record with dose times and meals shows your practice when the effect wears off.
The side effects of levodopa can be roughly divided into two groups: those that mainly occur at the start and often ease off, and those that only develop after years.¹
This is one of the two cores of this article — and one of the most frequently overlooked reasons why levodopa "is not working properly today".
Chemically, levodopa is related to the large neutral amino acids, the building blocks of protein such as leucine, phenylalanine or tyrosine. To get from the small intestine into the blood and from the blood into the brain, it uses the same transporters as these amino acids. After a protein-rich meal — meat, fish, eggs, dairy products, pulses, protein shakes — many amino acids queue up at these transporters at the same time. Levodopa has to join the back of the queue.¹,⁴
There is a second effect on top of that: fatty and large meals delay stomach emptying. But levodopa is only absorbed in the small intestine. If it stays in the stomach for longer, the effect arrives later and weaker.
Important for putting this in context: not every dip in effect has to do with food. In early stages many people notice nothing at all of the protein competition, because the buffer in the brain evens out fluctuations. It usually only becomes relevant once fluctuations in effect appear — but then often markedly.
After some years of treatment, many people notice that the effect of one dose no longer lasts until the next. These so-called motor fluctuations are not a treatment failure but a consequence of the disease progressing: the dopamine buffer in the brain shrinks, and the effect follows the short-lived blood level ever more closely.²
| Phenomenon | What it feels like | Typical approaches |
|---|---|---|
| Wearing-off (end-of-dose) | Before the next dose, stiffness, tremor or slowness return — predictably, often at the same times | Shorter intervals, additional effect-prolonging medicines, prolonged-release form |
| Delayed or absent "on" | A dose works late or not at all, often after eating or in the afternoon | Gap from meals, dispersible form, treating constipation |
| Early-morning immobility | Barely able to move after the night until the first dose works | Prolonged-release form at night, dispersible form in the morning |
| Excess movements at peak effect | Involuntary, dance-like movements when the effect is at its strongest | Smaller single doses, adjusting the additional medicines |
| Unpredictable on-off switches | Sudden switches between mobile and blocked, with no clear link to dose times | Specialist adjustment, possibly pump therapy or deep brain stimulation |
Often overlooked: when the effect wears off, it is not only movement symptoms that return. At the end of a dose, many people experience inner restlessness, anxiety, sweating, pain, low mood or problems concentrating. Because these symptoms do not look like "Parkinson's", they are rarely linked with the dose times — and rarely mentioned. If they regularly appear at the same time of day, they belong on your list for the appointment. Persistent low mood can also be a separate depression, which is common in Parkinson's.
At your appointment you may happen to be moving well — and the problem is invisible. That is exactly why an on-off diary is so valuable. A proven approach is to note the following on two to three typical days before the appointment:
From records like these, your practice can tell whether it is predictable wearing-off, competition with food or unpredictable fluctuations — and that determines the treatment. Standardised wearing-off questionnaires can also help. Doses, meals and your state can be recorded in the health history in the brite app.
The current guideline describes a broad spectrum: splitting the levodopa doses, adding effect-prolonging medicines (COMT inhibitors, MAO-B inhibitors), adding a dopamine agonist such as pramipexole, using as-needed medicines for sudden off phases and, in advanced stages, considering pump therapies or deep brain stimulation.² Which combination is right is a very individual decision that the treating neurology practice makes together with you.
With levodopa, the medicines that matter most are those that block dopamine in the brain — they cancel out its effect and can drastically worsen mobility.¹
| Combination | Consequence | What to do |
|---|---|---|
| Metoclopramide for nausea | Blocks dopamine in the brain, worsens Parkinson's symptoms | Avoid in Parkinson's; ask about alternatives |
| Classic antipsychotics (e.g. haloperidol) and many newer ones | Levodopa's effect is cancelled out, marked deterioration | Avoid; for psychosis only selected substances such as quetiapine or clozapine come into question |
| Non-selective MAO inhibitors | Risk of a hypertensive crisis | Contraindicated; selective MAO-B inhibitors, by contrast, are usual partners |
| Iron supplements | Reduced absorption of levodopa | Keep a time gap |
| Blood pressure lowering medicines | Greater drop in blood pressure on standing up | Check blood pressure while standing, adjust the dose if necessary |
| Sedatives and sleeping tablets | Increased tiredness, risk of falls | Only after seeking advice |
| Alcohol | Increases tiredness, dizziness and the drop in blood pressure | Hold back; see medications and alcohol |
The nausea dilemma: Metoclopramide is one of the most frequently prescribed medicines for nausea — including in emergency departments and after operations. In Parkinson's it can severely worsen mobility. The note "I have Parkinson's" therefore belongs in every medication history and on your medical emergency card.
One myth fewer: Vitamin B6 (pyridoxine) only weakens levodopa if levodopa is given without a decarboxylase inhibitor. Since practically only combination products are used today, this usually plays no role.¹
Because people with Parkinson's often receive many medicines from different doctors, it is worth looking at the complete list regularly. The interaction check in the brite app flags dopamine antagonists before they do any harm.
Levodopa is never stopped abruptly or suddenly reduced sharply. According to the SmPC, a condition resembling neuroleptic malignant syndrome can then develop: high fever, marked muscle stiffness, impaired consciousness, unstable circulation.¹ An akinetic crisis — almost complete immobility with difficulty swallowing — can also occur. Both are medical emergencies.
The danger usually comes not from deliberately stopping, but from situations in which doses are missed without anyone noticing:
A medical emergency card with the note "Parkinson's — medicines on time, no metoclopramide, no classic antipsychotics" can make all the difference in an emergency.
With age, susceptibility to hallucinations, confusion and drops in blood pressure increases. Levodopa is nevertheless considered comparatively well tolerated in older age — often better than dopamine agonists.² What matters is spotting other burdensome medicines, such as those with an anticholinergic effect. The guide medications in old age gives you your bearings.
People with Parkinson's have an increased risk of the skin cancer melanoma. Whether levodopa contributes to this has not been established; in any case, the SmPC recommends regular skin examinations.¹ This can easily be combined with skin cancer screening.
For narrow-angle glaucoma, severe heart, liver or kidney disease and certain psychiatric conditions, restrictions or contraindications apply according to the SmPC.¹ They should be put on the table before treatment starts and with every new diagnosis.
Parkinson's at a younger age is rare, and experience in pregnancy is limited. The SmPCs of the combination products differ here: for some, pregnancy is a contraindication; for others, a strict weighing of benefits and risks is required.¹ Levodopa also inhibits the milk-producing hormone prolactin and passes into breast milk. A wish to have children should therefore be planned in advance with the neurology practice.
In Germany, levodopa with benserazide is also licensed for restless legs syndrome — at a much lower dose. There the main problem is augmentation: the symptoms start earlier in the day, become stronger and spread. It occurs particularly often with levodopa, which is why in restless legs syndrome it is usually only used occasionally or for short periods. This article focuses on Parkinson's; the particular features of restless legs syndrome are described in the linked article.
Probably not. A large, protein-rich meal slows down the absorption of levodopa twice over: the stomach empties more slowly, and protein building blocks compete with the active ingredient for the same transport route. It often helps just to take the tablet about half an hour before eating and to have a lighter lunch. Note your dose, meal and mobility for a few days — then you and your practice can see whether the pattern holds. But do not cut protein overall; redistribute it instead.
This is early-morning immobility: after the night, the level is at its lowest. Some people put the first dose with a little water next to the bed and take it straight after waking up — half an hour before breakfast. Dispersible tablets work somewhat faster, and a prolonged-release form in the evening can bridge the night. Which option is right is decided by the treating practice; tell them specifically how long it takes in the mornings.
This worry is widespread, but according to current knowledge it is unfounded. Levodopa does not "get used up". A large study has shown that starting early neither speeds up nor slows down the course of the disease. Fluctuations in effect arise because the disease progresses and the dopamine buffer in the brain shrinks. If you delay levodopa out of fear, you may be giving up quality of life without gaining anything. Which substance is used first nevertheless remains an individual decision.
Unfortunately, this is a well-known problem. Ward routines follow fixed drug round times; Parkinson's medicines follow the clock. What helps is a printed medication plan with exact times, a note on your emergency card and asking to take your own medicines yourself, if you are able to. Raise it actively on admission — and ask your family to keep an eye on it.
The interaction check shows dopamine antagonists and spacing rules in your list.
A reminder for every single dose, an on-off history and an interaction check in one place. Free.
Create medication plan